Detected ·

AusperBio

$120M—

AusperBio raised $120M in Series C funding to advance a curative hepatitis B therapy targeting a ~$4B annual market.

Amount
$120 000 000 USD
Stage
—
Event
Funding round
Detected
2026-08-29 08:06:57 UTC
Signal ID
4201e5b5-9d84-4f1e-8c57-c973584c6950

As the API returns it

{
  "id": "4201e5b5-9d84-4f1e-8c57-c973584c6950",
  "created_at": "2026-08-29T08:06:57.507470Z",
  "company_name": "AusperBio",
  "company_website_url": "www.ausperbio.com",
  "company_linkedin_url": "https://www.linkedin.com/company/ausperbio",
  "event_type": "funding",
  "funding_amount": 120000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*AusperBio raised $120M in Series C funding to advance a curative hepatitis B therapy targeting a ~$4B annual market.*"
}

Latest rounds